Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
09/2005
09/15/2005US20050202016 Polypeptide; an amino acid sequence of the family of tumour-suppressing genes related to the gene for the p53 protein; isolated nucleic acid sequences coding for the proteins
09/15/2005US20050202014 Methods of blocking tissue destruction by autoreactive T cells
09/15/2005US20050202013 Novel Th2-specific molecules and uses thereof
09/15/2005US20050202011 Methods for inhibiting an immune response by blocking the GP39/CD40 and CTLA4/CD28/B7 pathways and compositions for use therewith
09/15/2005US20050202009 Novel MHC II associated peptides
09/15/2005US20050202008 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs
09/15/2005US20050202006 EGFH2 genes and gene products
09/15/2005US20050202002 Reagent; polyclonal or monoclonal antibody against the protease or its proenzyme which activates blood clotting factor VII, is inhibited by the presence of aprotinin, is increased in its activity by calcium ions, heparin, or heparin related substance
09/15/2005US20050202000 Polymerizing ability and cellular and humoral immunogenicity decreased as compared with the wild the wild-type staphylokinase; Mutant genes were constructed by PCR site-directed mutagenesis, then recombined with a prokaryotic vector and used to transform E. coli.; thrombolytics and anticoagulant
09/15/2005US20050201999 Compounds and methods for identifying compounds which inhibit a new class of aspartyl proteases
09/15/2005US20050201986 Cell targeting compositions and methods of using the same
09/15/2005US20050201983 Capsid and capsid-expressing genome modified to display heterologous peptide(s) to allow nuclear or subcellular targeting by delivering a peptide into the cell nucleus; easy construction of libraries using site-specific recombination in vitro; peptide/protein fusion with capsid protein vp39 (AcMNPV)
09/15/2005US20050201982 Polynucleotides encoding interferon gamma peptide variants
09/15/2005US20050201979 Reduced vasopermeability activity and similar binding affinity for an IL-2 receptor compared to its wildtype form; immunostimulants; immuotherapy; anticarcinogenic agents; renal cell cancer, melanoma; chemotherapy and/or radiation therapy; viricides; human immunodeficiency virus; autoimmune disorders
09/15/2005US20050201977 Amino-terminally truncated MCP-2 as chemokine antagonists
09/15/2005US20050201976 Selective inhibitors of nuclear factor-kappaB activation and uses thereof
09/15/2005US20050201975 Modifying chemokine G-protein mediated signalling and/or signal transduction by administering a modulator of the Notch signalling pathway; using a fusion protein of a segment of a Notch ligand extracellular domain and an immunoglobulin Fc segment or a polynucleotide encoding it; antiinflammatory agents
09/15/2005US20050201973 Therapeutic supramolecules
09/15/2005US20050201934 Binding peptides for carcinoembryonic antigen (CEA)
09/15/2005US20050201932 Drug delivery using Polymeric immunoglobulin receptor (pIgR) which when cleaved has a stalk region which remains attached to the cell and a secretory component (SC) which exists in an organ of interest in several forms
09/15/2005US20050201481 Method and apparatus for data transmission using multiple transmit antennas
09/15/2005US20050199498 Electrophoresis; fibrinogen
09/15/2005EP1585960A3 Mucin immobilized chromatography
09/15/2005DE102004009453A1 Verfahren zur Herstellung von L-Aminosäuren unter Verwendung von coryneformen Bakterien A method for producing L-amino acids using coryneform bacteria
09/15/2005DE102004009018A1 Verfahren zur Modulation Gibberellinsäure-abhängiger Prozesse in Pflanzen A method of modulating gibberellin-dependent processes in plants
09/15/2005CA2566307A1 Canine ghrh gene, polypeptides and methods of use
09/15/2005CA2560066A1 Natural igm antibodies and inhibitors thereof
09/15/2005CA2558839A1 Plants having improved yield and method for making the same
09/15/2005CA2558721A1 Screening method for emulators of neural activity and digestive system using gpr35
09/15/2005CA2558664A1 Functional method for generating or screening for ligands which modulate steroid hormone receptors
09/15/2005CA2558660A1 Fusion proteins comprising modified allergens of the ns-ltps family, use thereof and pharmaceutical compositions comprising the same
09/15/2005CA2558656A1 Insecticidal toxin complex fusion proteins
09/15/2005CA2558586A1 Recombinant varicella-zoster virus
09/15/2005CA2558436A1 Method of proliferating precursor cells
09/15/2005CA2558408A1 Compositions and methods for topical application and transdermal delivery of botulinum toxins
09/15/2005CA2558399A1 Partially loaded antibodies and methods of their conjugation
09/15/2005CA2558084A1 Method of modifying plant seeds comprising modulating expression of mint transcription factor
09/15/2005CA2557953A1 Preparation of recombinant rotavirus proteins in milk of transgenic non human mammals
09/15/2005CA2557788A1 Mutein of a bone morphogenetic protein and use thereof
09/15/2005CA2557654A1 Peptides of il1 beta and tnf alpha and method of treatment using same
09/15/2005CA2555656A1 New proliferation markers in clinical practice and their use for cancer prognosis or diagnosis
09/15/2005CA2555612A1 Compositions and methods for the treatment and clinical remission of psoriasis
09/15/2005CA2554966A1 Methods and compostions for targeted cleavage and recombination
09/15/2005CA2554596A1 Il-4/il-13 specific polypetides and therapeutic uses thereof
09/15/2005CA2552420A1 Method of assessing rheumatoid arthritis by measuring anti-ccp and serum amyloid a
09/15/2005CA2529752A1 Polypeptide transduction and fusogenic peptides
09/14/2005EP1574579A2 Outer surface proteins, their genes, and their use
09/14/2005EP1574578A1 Monomeric protein of the TGF-beta family
09/14/2005EP1574577A2 Growth differentiation factor-11
09/14/2005EP1574576A1 Novel human ion channel protein and polynucleotides encoding the same
09/14/2005EP1574575A1 GLUCOSE AND/OR FRUCTOSE TRANSPORTER NaGLT1 AND ITS GENE
09/14/2005EP1574566A1 A microbial process for arginine production
09/14/2005EP1574520A2 Methods and materials relating to neuronal guidance molecule-like (NGM-like) polypeptides and polynucleotides
09/14/2005EP1574519A1 Transcription control factor ZHX3
09/14/2005EP1574518A2 Venom-derived vascular endothelial growth factor-like protein having binding activity specific to vascular endothelial growth factor receptor type 2 and use thereof
09/14/2005EP1574517A1 HCV E1 comprising specific disulfide bridges
09/14/2005EP1573324A2 Cytochrome c acetylation
09/14/2005EP1573323A2 Prion protein ligands and methods of use
09/14/2005EP1573314A2 Transgenic mice expressing human cd20
09/14/2005EP1573313A2 Transgenic mice expressing human cd20 and/or cd16
09/14/2005EP1573063A2 Treatment of liver deseases
09/14/2005EP1573047A2 Lectin compositions and methods for modulating an immune response to an antigen
09/14/2005EP1573046A2 Protease resistant ti-growth hormone releasing hormone
09/14/2005EP1573041A2 Detection and typing of human papillomavirus using pna probes
09/14/2005EP1573035A2 Brother of the regulator of imprinted sites (boris)
09/14/2005EP1573034A2 Identification and modulation of a g-protein coupled receptor (gpcr), rai3, associated with chronic obstructive pulmonary disease (copd) and nf-kb and e-selectin regulation
09/14/2005EP1573032A2 Human il-18 crystal structure
09/14/2005EP1573031A2 Androgen regulated nucleic acid molecules and encoded proteins
09/14/2005EP1573028A2 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
09/14/2005EP1573025A2 Crystallized structure of type iv collagen nc1 domain hexamer
09/14/2005EP1573024A2 Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
09/14/2005EP1573023A2 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer
09/14/2005EP1573022A2 Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer
09/14/2005EP1573021A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
09/14/2005EP1573020A2 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
09/14/2005EP1573017A1 Preparation of antifreeze protein
09/14/2005EP1573012A1 Recombinant viral-based malaria vaccines
09/14/2005EP1573011A1 Method for preparing recombinant heterocarpine
09/14/2005EP1573010A1 Methods and means for modulating cellulose biosynthesis in fiber producing plants
09/14/2005EP1573006A2 Il-21 production in prokaryotic hosts
09/14/2005EP1572995A2 Novel proteins and nucleic acids encoding same
09/14/2005EP1572991A2 Compositions and methods for hydroxilating epothilones
09/14/2005EP1572987A2 Novel nucleic acids and polypeptides
09/14/2005EP1572983A1 Culture chamber for biologicals
09/14/2005EP1572975A2 Streptococcus uberis adhesion molecule
09/14/2005EP1572968A2 Lutzomyia longipalpis polypeptides and methods of use
09/14/2005EP1572967A2 Il-1 receptor based antagonists and methods of making and using
09/14/2005EP1572965A2 Human sarcoma-associated antigens
09/14/2005EP1572963A2 Carbohydrate-based synthetic vaccines for hiv
09/14/2005EP1572961A2 Actriib fusion polypeptides and uses therefor
09/14/2005EP1572960A2 Identification of a novel bitter taste receptor, t2r76
09/14/2005EP1572957A2 Identification of polynucleotides for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in breast cells
09/14/2005EP1572954A2 Npc1l1 (npc3) and methods of use thereof
09/14/2005EP1572952A2 Novel polynucleotide and polypeptide sequences and uses thereof
09/14/2005EP1572951A2 Nucleotide sequences that code for torsin genes, torsin proteins, and methods of using the same to treat protein-aggregation
09/14/2005EP1572950A2 Single domain tdf-related compounds and analogs thereof
09/14/2005EP1572947A2 RECOVERY OF RECOMBINANT HUMAN PARAINFLUENZA VIRUS TYPE 2 (HPIV2) FROM cDNA AND USE OF RECOMBINANT HPIV2 IN IMMUNOGENIC COMPOSITIONS AND AS VECTORS TO ELICIT IMMUNE RESPONSES AGAINST PIV AND OTHER HUMAN PATHOGENS
09/14/2005EP1572944A2 Methods and compositions for modulating xbp-1 activity
09/14/2005EP1572942A2 Live replicating spumavirus vector
09/14/2005EP1572941A2 Novel flavivirus antigens
1 ... 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 ... 2916